INTRODUCTION
============

Voltage-gated calcium (Ca~V~) channels are expressed in most excitable cells and facilitate Ca^2+^ entry in response to membrane depolarization. Among the 10 types of Ca~V~ channels, R-type Ca~V~2.3 channels belong to the high voltage-activated (HVA) calcium channel family and are broadly expressed in the brain area, including the hippocampus, amygdala, olfactory bulb, and frontal cortex ([@b24-molce-39-4-322]; [@b35-molce-39-4-322]; [@b43-molce-39-4-322]). The Ca~V~2.3 channels play important roles in neurotransmitter release, pain transmission, and fear ([@b19-molce-39-4-322]; [@b33-molce-39-4-322]; [@b44-molce-39-4-322]). Despite high sequence homology among α1 subunits of the Ca~V~2 family, Ca~V~2.3 channels have different gating properties and pharmacological characteristics from those of Ca~V~2.1 and Ca~V~2.2 channels. Ca~V~2.3 channels are activated at a lower voltage than other Ca~V~2 channels. In addition, the kinetics for activation and inactivation of Ca~V~2.3 currents are faster than those of Ca~V~2.2 channels. From a pharmacological perspective, Ca~V~2.3 channels are insensitive to Ca~V~2.1 and Ca~V~2.2 channel blockers ([@b35-molce-39-4-322]; [@b43-molce-39-4-322]). Another significant difference between Ca~V~2.3 channels and other Ca~V~2 channels is the modulation by G-protein-coupled receptors (GPCRs). As a G~q~-protein-coupled receptor, M~1~ muscarinic receptor (M~1~R) activation results in degradation of plasma membrane PI(4,5)P~2~. According to previous studies, Ca~V~2.3 channel gating is enhanced by M~1~R stimulation, probably through the activation of Ca^2+^-independent protein kinase C (PKC) ([@b2-molce-39-4-322]; [@b21-molce-39-4-322]; [@b42-molce-39-4-322]). On the other hand, Ca~V~2.1 and Ca~V~2.2 channels are known to be suppressed by M~1~R activation, and this suppression turned out to be owing to Gβγ-mediated signaling pathways and/or PI(4,5)P~2~ depletion ([@b6-molce-39-4-322]; [@b15-molce-39-4-322]; [@b16-molce-39-4-322]; [@b22-molce-39-4-322]; [@b28-molce-39-4-322]; [@b29-molce-39-4-322]; [@b34-molce-39-4-322]). One previous study reported that Ca~V~2.3 channels were slowly inhibited by G~q/11~-coupled neurokinin 1 receptors ([@b23-molce-39-4-322]). The molecular mechanism of slow inhibition was not identified, but they proposed that the depletion of membrane PI(4,5)P~2~ may be involved in the inhibitory pathway.

In this paper, we further investigated whether Ca~V~2.3 channels are sensitive to plasma membrane PI(4,5)P~2~ depletion. PI(4,5)P~2~ hydrolysis by M~1~R-mediated phospholipase C (PLC) activation results in the generation of several intracellular secondary molecules, such as inositol 1,4,5-trisphosphate (IP~3~) and diacylglycerol (DAG), as well as the increase of intracellular Ca^2+^ concentration and PKC activity. Hence, here we employed voltage-sensitive phosphatase from zebrafish (Dr-VSP) and chemically inducible dimerization (CID) systems, which directly and selectively dephosphorylate PI(4,5)P~2~ in the plasma membrane without producing any other second messengers. By using these methods, we observed that Ca~V~2.3 channels are modulated by M~1~R through the modification of the membrane PI(4,5)P~2~ level. Together, our data demonstrate that Ca~V~2.3 channels are regulated by M~1~R through dual modulatory pathways: activation through PKC activation and inhibition through PI(4,5)P~2~ depletion.

MATERIALS AND METHODS
=====================

Materials
---------

The following cDNAs were gifted to us: rat α1E (accession number NM_019294) from Terrance P. Snutch, University of British Columbia; rat α1B (accession number NM_001195199), β3 (accession number NM_012828), and α2δ1 (accession number NM_012919) from Diane Lipscombe, Brown University, Providence, RI; rat M~1~-muscarinic receptor (accession number NM_080773) from Neil N. Nathanson, University of Washington, WA; Dr-VSP with EGFP from Yasushi Okamura, Osaka University, Osaka, Japan; Lyn~11~-FRB, PJ-Dead, PJ-Sac, INPP5E, PJ, and PH-PLCδ-GFP from Bertil Hille, University of Washington School of Medicine, Seattle, Washington.

Cell culture and transfection
-----------------------------

Human embryonic kidney cell-derived tsA201 cells were maintained in Dulbecco's Modified Eagle's Medium (DMEM, Invitrogen, USA) supplemented with 10% fetal bovine serum (FBS, Invitrogen, USA), and 0.2% penicillin/streptomycin (Invitrogen, USA) in 100-mm culture dishes. In all experiments, for calcium channel expression, the α1B or α1E of Ca~V~, β3, and α2δ1 subunits were transiently transfected into tsA201 cells in a 1:1:1 ratio. In some cases, 1 μg of M~1~R or 1 μg of Dr-VSP was co-transfected. For the rapamycin-inducible dimerization experiment, 200 ng of Lyn~11~-FRB and 300 ng of translocatable enzymes (PJ-Dead, PJ-Sac, INPP5E, and PJ) were co-transfected. In addition, for the confocal experiment, 200 ng of PH-PLCδ-GFP was co-transfected. The cells were allowed to grow on a 35-mm culture dish and transfection was performed when the confluency of cells reached 60--70%. Lipofectamine 2000 (10 μl; Invitrogen, USA) was added to 250 μl of DMEM and then left for 5 min. cDNA was applied with another 250 μl DMEM. Both solutions were mixed and incubated for 15 min in a dark space, then the transfectant mixture was added to cells. After 4 h, fresh culture media containing FBS and antibiotics was exchanged. Transfected cells were plated on the poly-L-lysine-coated (0.1 mg/ml, Sigma-Aldrich, USA) chip 48 h later for the electrophysiological experiment or 24 h later for the confocal experiment after transfection.

Solutions
---------

The bath solution used to record Ba^2+^ currents contained (in mM) 10 BaCl~2~, 150 NaCl, 1 MgCl~2~, 10 HEPES, and 8 glucose (adjusted to pH 7.4 with NaOH). The pipette solution contained (in mM) 175 CsCl~2~, 5 MgCl~2~, 5 HEPES, 0.1 1,2-bis(2-aminophenocy)ethane N,N,N′,N′-tetraacetic acid (BAPTA), 3 Na~2~ ATP, and 0.1 Na~3~GTP (adjusted to pH 7.4 with CsOH). The external solution for confocal imaging contained (in mM) 160 NaCl, 2.5 KCl, 2 CaCl~2~ H~2~O, 1 MgCl~2~, 10 HEPES, and 8 glucose (adjusted to pH 7.4 with NaOH). The bath solutions were stored in a refrigerator at 4°C. The pipette solution was stored in a freezer at −20°C. BAPTA, Na~2~ATP, Na~3~GTP, CsOH, and BaCl~2~ reagents were obtained from Sigma-Aldrich (USA), HEPES was from Calbiochem (USA), and other chemicals were obtained from Merck (Germany).

Chemicals
---------

Oxotremorine-M (Oxo-M, Sigma-Aldrich, USA) was dissolved in sterile water to make a 10 mM stock and was stored at −20°C. Both phorbol 12-myristate 13-acetate (PMA, Enzo life sciences, USA) and rapamycin (LC Laboratories, USA) were dissolved in dimethyl sulfoxide (DMSO, Sigma-Aldrich, USA) to make 100 μM and 5 mM stocks, respectively. All chemicals were stored at −20°C. They were diluted with bath solution before being applied to cells.

Current recording
-----------------

All currents were obtained at room temperature (22--25°C). Patch pipettes (1--4 MΩ) were pulled from borosilicate glass micropipette capillaries (1.5 mm outer diameter; 1.1 mm inner diameter; and 10 cm length) (Sutter Instrument Company, USA). The whole-cell configuration was used to record Ba^2+^ currents. In cell attached mode, a gigaohm seal was formed, and the plasma membrane was ruptured by negative pressure. Series resistance was 3.6--6 MΩ and was compensated by 60%. A HEKA EPC-10 amplifier with pulse software (HEKA Elektronik) was used for current recording. Ba^2+^ currents were recorded with a membrane holding potential of −80 mV, and a 100-ms test pulse (+ 10 mV for Ca~V~2.2 channels and 0 mV for Ca~V~2.3 channels) was applied every 4 s.

For Dr-VSP experiments, the following protocol was used. First, test pulse a (+10 mV for Ca~V~2.2 channels and 0 mV for Ca~V~2.3 channels) was applied for 10 ms. This current became the baseline. Then, +120 mV was generated for 1 s to activate Dr-VSP and to deplete PI(4,5)P~2~. Following the large depolarizing pulse, −150 mV hyperpolarizing pulse was applied for 400 ms to remove calcium channel inactivation. Finally, test pulse b was applied. Currents a and b, before and after PI(4,5)P~2~ depletion by Dr-VSP activation, were compared to calculate the ratio of current inhibition.

Confocal imaging
----------------

Confocal images were obtained with a Carl Zeiss Inverted LSM 700 confocal microscope (Carl Zeiss AG, GFP by argon-ion laser and mRFP by blue diode laser) at room temperature (22--25°C). In time course, images were obtained by scanning cells with a 40× (water) objective lens at 512 × 512 pixels, and were taken every 10 s for 5 min. For the single image, cells were scanned with a 40× (water) objective lens at 1024 × 1024 pixels. Cytosolic fluorescence intensity was measured by using ZEN2010 software (Carl Zeiss) and was processed with Microsoft Office Excel 2010 (Microsoft) or Igor Pro (WaveMetrics, Inc.).

Data analysis
-------------

For data acquisition and analysis, a HEKA EPC-10 amplifier (HEKA Elektronik) was used. Additional data processing was accomplished with Igor Pro (WaveMetrics, Inc.) and Microsoft Office Excel 2010 (Microsoft). Time constants for the responses were obtained by fitting the data to a single-exponential function. All quantitative data were expressed as the mean ± standard error of the mean (SEM). Student's *t*-test was used for comparisons between two groups. One-way ANOVA was used for comparisons between more than two groups.

RESULTS
=======

To record calcium channel currents, tsA201 cells were transfected with α1B for Ca~V~2.2 currents or α1E for Ca~V~2.3 currents plus auxiliary subunits β3 and α2δ1. We used Ba^2+^ as a charge carrier instead of Ca^2+^ to rule out calcium-dependent inactivation and other unexpected events triggered by Ca^2+^ ions ([@b20-molce-39-4-322]). In all experiments, we measured the channel activity of both Ca~V~2.2 and Ca~V~2.3, where the Ca~V~2.2 current was measured as a control for PI(4,5)P~2~ regulation because it is known to be inhibited by M~1~R activation ([@b17-molce-39-4-322]; [@b41-molce-39-4-322]). To obtain the peak currents, +10 mV and 0 mV were applied for Ca~V~2.2 and Ca~V~2.3 channels, respectively.

Differential modulation of Ca~V~2.2 and Ca~V~2.3 channels by M~1~ muscarinic receptors
--------------------------------------------------------------------------------------

Whereas most HVA calcium channels are known to be inhibited by M~1~R activation, Ca~V~2.3 channels are further activated by M~1~R activation ([@b21-molce-39-4-322]; [@b40-molce-39-4-322]). When tsA201 cells co-transfected with M~1~R and either Ca~V~2.2 or Ca~V~2.3 channels were treated with muscarinic receptor agonist Oxo-M (10 μM) for 60 s, Ca~V~2.2 (N-type) currents were rapidly decreased by 55 ± 2% (n = 13, [Figs. 1A and 1C](#f1-molce-39-4-322){ref-type="fig"}), while Ca~V~2.3 (R-type) currents were increased by 83 ± 7% (n = 9, [Figs. 1B and 1C](#f1-molce-39-4-322){ref-type="fig"}). These differential results were consistent with those of previous studies ([@b21-molce-39-4-322]; [@b28-molce-39-4-322]; [@b30-molce-39-4-322]; [@b40-molce-39-4-322]).

According to previous studies, phosphorylation of Ca~V~ α1 subunits by PKC could activate Ca~V~2.3 channels ([@b5-molce-39-4-322]; [@b13-molce-39-4-322]; [@b14-molce-39-4-322]; [@b31-molce-39-4-322]; [@b36-molce-39-4-322]). Based on these studies, we decided to verify the effect of PKC on both Ca~V~2.2 and Ca~V~2.3 currents. The bath solution containing 1 μM phorbol 12-myristate 13-acetate (PMA), which is a DAG analog recruiting PKC to the plasma membrane, was applied to the cells for 120 s. While Ca~V~2.2 currents were not significantly changed by PMA application ([Fig. 2A](#f2-molce-39-4-322){ref-type="fig"}), Ca~V~2.3 currents increased almost two-fold ([Fig. 2B](#f2-molce-39-4-322){ref-type="fig"}). Interestingly, we found that after full activation of Ca~V~2.3 channels by PKC activation, M~1~R activation decreased the Ca~V~2.3 currents by 52 ± 8% (n = 5), similarly to Ca~V~2.2 currents (47 ± 5%, n = 9) ([Fig. 2C](#f2-molce-39-4-322){ref-type="fig"}). The time constants for Oxo-M-induced inhibition of Ca~V~2.2 currents and Ca~V~2.3 currents were 4 ± 0 s (n = 9) and 12 ± 2 s (n = 5), respectively ([Fig. 2D](#f2-molce-39-4-322){ref-type="fig"}). Collectively, our results showed that after full activation of PKC, Ca~V~2.3 channels were also inhibited by M~1~R activation, which is very similar to Ca~V~2.2 channels.

Ca~V~2.3 currents are decreased by Dr-VSP activation
----------------------------------------------------

Since M~1~ muscarinic inhibition of voltage-gated calcium channels (VGCCs) is known to be partially due to PI(4,5)P~2~ depletion through PLCβ enzyme activation ([@b6-molce-39-4-322]), we decided to test the effect of PI(4,5)P~2~ depletion on Ca~V~2.3 channels. Dr-VSP was used to transiently dephosphorylate PI(4,5)P~2~ in the plasma membrane in response to membrane depolarization and to exclude the effects of the other secondary signaling molecules generated by M~1~R activation ([@b25-molce-39-4-322]; [@b40-molce-39-4-322]). The protocols used for activating Dr-VSP are represented in [Fig. 3A](#f3-molce-39-4-322){ref-type="fig"}. In tsA201 cells expressing both Ca~V~2.2 channels and Dr-VSP, Ca~V~2.2 currents were decreased by 40 ± 4% (n = 9) after a 1-s depolarizing pulse. In contrast, there was no significant change in the control (-Dr-VSP) ([Figs. 3B left and 3C](#f3-molce-39-4-322){ref-type="fig"}). Similarly, Ca~V~2.3 currents in cells expressing Dr-VSP were decreased by 38 ± 1% (n = 6) in response to PI(4,5)P~2~ depletion, while the control cells were not ([Figs. 3B right and 3D](#f3-molce-39-4-322){ref-type="fig"}). These results suggest that the depletion of PI(4,5)P~2~ by Dr-VSP activation inhibits both Ca~V~2.2 and Ca~V~2.3 channels.

Ca~V~2.3 channels are inhibited by rapamycin-inducible pseudojanin systems
--------------------------------------------------------------------------

To further examine the regulatory effects of membrane PIs on Ca~V~2.3 currents, we employed the recently developed rapamycin-induced translocatable PI phosphatase system ([@b9-molce-39-4-322]). In the system, the PI phosphatase is conjugated with FK506-binding protein 12 (FKBP), one of the dimerization subunits. The phosphatase-containing subunit can be recruited to the plasma membrane by application of rapamycin to the cells expressing the plasma membrane-targeting LDR subunit. By using this method, we can selectively and irreversibly deplete the specific PIs in the plasma membrane. Three constructs were used to manipulate the plasma membrane PIs: PJSac, INPP5E, and PJ ([Fig. 4A](#f4-molce-39-4-322){ref-type="fig"}). PJ-Sac is 4-phosphatase from *S. cerevisiae* sac1. This enzyme dephosphorylates PI(3)P, PI(4)P and PI(3,5)P~2~, but not PI(4,5)P~2~ ([@b7-molce-39-4-322]). INPP5E, inositol polyphosphate-5-phosphatase E, is 5-phosphatase, and its substrates are PI(4,5)P~2~ and PI(3,4,5)P~3~ ([@b3-molce-39-4-322]). PJ contains both active PJ-Sac and INPP5E domains; thus, this translocatable enzyme can deplete both PI(4,5)P~2~ and PI(4)P by sequentially dephosphorylating 5-and 4-phosphates. Unlike PJ, PJ-Dead is inactive in both phosphatases. Lyn~11~, a plasma membrane-targeting motif ([@b12-molce-39-4-322]), is fused with FKBP-rapamycin binding protein (FRB). When rapamycin is added, FKBP and FRB form a ternary complex with rapamycin. Hence, the phosphatase conjugated to FKBP is recruited to the plasma membrane and dephosphorylates its substrates ([Fig. 4B](#f4-molce-39-4-322){ref-type="fig"}).

The movement of translocatable enzymes was monitored using confocal microscopy every 10 s. TsA201 cells were co-transfected with Lyn~11~-FRB and one of the following four translocatable enzymes tagged with mRFP: PJ-Dead, PJ-Sac, INPP5E, or PJ. The cells were also transfected with the pleckstrin homology (PH) domain of PLCδ labeled with GFP (PH-PLCδ-GFP) as a PI(4,5)P~2~-specific probe. The PH domain of PLCδ binds to the head group of PI(4,5)P~2~ so we can detect plasma membrane PI(4,5)P~2~ in live cells.

Cells expressing both PH-PLCδ-GFP (green) and translocatable enzymes (red) are shown in [Fig. 4C](#f4-molce-39-4-322){ref-type="fig"}. At first, PH-PLCδ-GFP is present in the plasma membrane, while the translocatable enzymes, including PJ-Dead, PJ-Sac, INPP5E, and PJ, exist in the cytosol. After the application of 1 μM rapamycin, all the translocatable enzymes were commonly translocated to the plasma membrane. However, the movement of PH-PLCδ-GFP from the plasma membrane to the cytosol was different depending on the translocatable enzymes. In cells co-transfected with PJ-Dead, the cytosolic fluorescence intensity of PH-PLCδ-GFP was almost the same before and after the rapamycin application (8 ± 2%, n = 4) ([Figs. 4D and 4E](#f4-molce-39-4-322){ref-type="fig"}). However, in cells expressing PJ-Sac, PH-PLCδ-GFP was significantly dissociated from plasma membrane and the cytosolic fluorescence intensity was increased by 24 ± 4% (n = 10). When the INPP5E or PJ systems were applied, the increase in cytosolic fluorescence intensity by INPP5E (44 ± 2%, n = 7) and PJ (48 ± 7%, n = 9) was further increased ([Figs. 4D and 4E](#f4-molce-39-4-322){ref-type="fig"}). We also measured time constants (τ) for the translocation of enzymes as well as PH-PLCδ-GFP. As in a previous study by Dickson et al. (2004), we also used time-series images taken every 10 s for resolving the τ value. There was no difference in τ value between translocatable enzymes. However, when the PJ-Sac transfected, the time constant of the rapamycin-induced increase in cytosolic PH-PLCδ-GFP intensity was 25 ± 3 s (n = 10), relatively slower than those of INPP5E 17 ± 1 s (n = 8) and PJ 15 ± 3 s (n = 9) ([Fig. 4F](#f4-molce-39-4-322){ref-type="fig"}). In summary, our results show that PJ-Sac might be involved in PI(4,5)P~2~ depletion, but the rate of PI(4,5)P~2~ dephosphorylation by PJ-Sac was slower than those of INPP5E and PJ. Based on these data, it suggests that PJSac dephosphorylates PI(4)P, and dephosphorylation of PI(4)P induces PI(4,5)P~2~ depletion.

We then measured the Ca~V~2.2 and Ca~V~2.3 current changes when the translocatable enzymes moved to the plasma membrane and dephosphorylated their PI substrates. The tsA201 cells were transfected with Ca~V~2 channel, Lyn~11~-FRB, and one of the following phosphatases: PJ-Dead, PJ-Sac, INPP5E, and PJ. The external solution containing 1 μM of rapamycin was perfused for 60 s. The recruitment of PJ-Dead had no significant effects on the currents ([Figs. 5A and 5B](#f5-molce-39-4-322){ref-type="fig"}). Ca~V~2.2 currents in cells expressing PJ-Sac were decreased by 39 ± 5% (n = 9) and the currents expressing INPP5E were decreased by 37 ± 3% (n = 5). When the cells were co-transfected with PJ, the currents were inhibited by 56 ± 4% (n = 11). Because of the irreversibility of rapamycin-induced FKBP-FRB dimerization ([@b39-molce-39-4-322]), the current amplitudes were not recovered and remained stable even after washout of rapamycin. The inhibition of Ca~V~2.2 currents by the recruitment of PJ-Sac took longer time (29 ± 2 s, n = 9) than that of INPP5E (10 ± 1 s, n = 5) or PJ (7 ± 4 s, n=11) ([Fig. 5C](#f5-molce-39-4-322){ref-type="fig"}).

We also examined the effects of the translocation of pseudojanin constructs on Ca~V~2.3 channel regulation. The tendency for a decrease in Ca~V~2.3 current was similar to that of Ca~V~2.2 channels. The translocation of PJ-Dead had no significant effect on the Ca~V~2.3 currents (3 ± 5%, n = 3). The membrane recruitment of PJ-Sac decreased the Ca~V~2.3 currents by 37 ± 4% (n = 5), while INPP5E decreased the currents by 53 ± 3% (n = 6). Lastly, PJ induced the strongest decrease in Ca~V~2.3 current (66 ± 3%, n = 7) ([Figs. 6A and 6B](#f6-molce-39-4-322){ref-type="fig"}). Like Ca~V~2.2 cur-Ca~V~2.3 current amplitudes were not recovered and remained stable even after rapamycin washout. The time constant for decreasing the Ca~V~2.3 currents by translocation of PJ-Sac was much slower (39 ± 3 s, n = 5) than that of INPP5E (11 ± 1 s, n = 6) or PJ (9 ± 1 s, n = 7) ([Fig. 6C](#f6-molce-39-4-322){ref-type="fig"}). These results also suggested that Ca~V~2.3 currents were suppressed mostly by depletion of PI(4,5)P~2~ in the plasma membrane.

DISCUSSION
==========

Even though PI(4,5)P~2~ is known as a crucial regulator of many types of ion channels, including high-voltage activated Ca~V~ channels ([@b10-molce-39-4-322]; [@b11-molce-39-4-322]; [@b32-molce-39-4-322]; [@b37-molce-39-4-322]; [@b38-molce-39-4-322]), it is not clear whether PI(4,5)P~2~ in the plasma membrane can regulate Ca~V~2.3 channels. In this study, we showed that Ca~V~2.3 channel can be suppressed by PI(4,5)P~2~ depletion. This inhibition was proved by direct and selective dephosphorylation of PI(4,5)P~2~ in the plasma membrane by using Dr-VSP ([Fig. 3](#f3-molce-39-4-322){ref-type="fig"}) and rapamycin-induced translocatable (CID) systems ([Figs. 5](#f5-molce-39-4-322){ref-type="fig"} and [6](#f6-molce-39-4-322){ref-type="fig"}).

The α1E gene used in our experiments is rbE-II extracted from rat brain ([@b35-molce-39-4-322]). The amino-terminus of rbE-II is shorter than other isoforms isolated from mouse, human, and rabbit at about 50 amino acids long. Owing to the short amino terminus, rbE-II is insensitive to voltage-dependent, membrane-delimited inhibition by Gβγ subunits ([@b27-molce-39-4-322]). In our study, we showed that this α*1E* isoform can be regulated by the voltage-independent, PI(4,5)P~2~-dependent pathway. Owing to the sequence homology between mammalian α1E (over 93%) ([@b43-molce-39-4-322]), we speculate that the modulation pattern by M~1~R activation might be similar.

As shown in [Fig. 1B](#f1-molce-39-4-322){ref-type="fig"}, when M~1~R is activated, the Ca~V~2.3 current is increased in two phases; an initial steep increase followed by a slow increase. The data suggest that there are two factors involved in Ca~V~2.3 channel regulation. Previous studies showed that M~1~R induces an increase in the Ca~V~2.3 current through PKC-mediated phosphorylation. However, in our study, we observed that Ca~V~2.3 is also regulated by PI(4,5)P~2~ depletion. The reason that the inhibitory effect of PI(4,5)P~2~ depletion on Ca~V~2.3 currents was hidden might be owing to the stronger effect of PKC on Ca~V~2.3 currents. In other words, the PI(4,5)P~2~ effect seems to be masked by PKC-induced potentiating effects. Why is the PKC effect on Ca~V~2.3 channels stronger than on other types of Ca~V~2 channels? That may be owing to several potential phosphorylation sites in the α1E subunit. As mentioned in the introduction, Ca~V~2.3 channels are potentiated by PKC activation. Previous studies showed that both Ca~V~2.2 and Ca~V~2.3 channels have possible sites for phosphorylation by PMA ([@b8-molce-39-4-322]; [@b46-molce-39-4-322]), which are embedded in the I--II loop of the α1 subunit ([@b5-molce-39-4-322]; [@b13-molce-39-4-322]; [@b14-molce-39-4-322]). However, Ca~V~2.3 channels have more phosphorylation sites than Ca~V~2.2 channels in the II--III loop. Indeed, the sequences of the II--III loop between Ca~V~2.3 channels and Ca~V~2.1 or Ca~V~2.2 channels show many differences ([@b35-molce-39-4-322]). Application of acetyl-β-methylcholine (MCh), another PKC activator, induced phosphorylation in the II--III loop and further increased the Ca~V~2.3 currents ([@b14-molce-39-4-322]; [@b31-molce-39-4-322]).

According to our results, the inhibition ratio of Ca~V~2.2 and Ca~V~2.3 currents by the translocation of PJ was greater than that of INPP5E ([Figs. 5B](#f5-molce-39-4-322){ref-type="fig"} and [6B](#f6-molce-39-4-322){ref-type="fig"}), but the time constants of inhibition by INPP5E and PJ were similar ([Figs. 5C](#f5-molce-39-4-322){ref-type="fig"} and [6C](#f6-molce-39-4-322){ref-type="fig"}). This might be owing to the rapid turnover between PI(4)P and PI(4,5)P~2~ ([@b26-molce-39-4-322]; [@b45-molce-39-4-322]). In the plasma membrane, PI(4,5)P~2~ is continuously and rapidly regenerated from PI(4)P by phosphatidylinositol 4-phosphate 5-kinase ([@b1-molce-39-4-322]; [@b45-molce-39-4-322]). Since both INPP5E and PJ directly dephosphorylate PI(4,5)P~2~, the time constants of inhibition in Ca~V~2.2 or Ca~V~2.3 current were similar. However, INPP5E does not deplete PI(4)P, which is a precursor of PI(4,5)P~2~; thus, PI(4,5)P~2~ can be rapidly resynthesized from PI(4)P during the INPP5E application and replenished in the plasma membrane. This may be the cause of the lower inhibition of currents by INPP5E compared to PJ.

We also found that in cells expressing PJ-Sac with channels, the Ca~V~2.2 or Ca~V~2.3 currents were decreased by translocation of PJ-Sac to the plasma membrane ([Figs. 5B](#f5-molce-39-4-322){ref-type="fig"} and [6B](#f6-molce-39-4-322){ref-type="fig"}). However, the time constant (τ) of current inhibition by PJ-Sac was greater compared with that of inhibition by INPP5E or PJ ([Figs. 5C](#f5-molce-39-4-322){ref-type="fig"} and [6C](#f6-molce-39-4-322){ref-type="fig"}). As shown in the confocal experiments, we observed that four enzymes were translocated to the plasma membrane immediately after the rapamycin application. We also observed that the increase in cytosolic PH-PLCδ-GFP intensity by PJ-Sac was lower than that of INPP5E or PJ ([Fig. 4E *right*](#f4-molce-39-4-322){ref-type="fig"}), but the τ of PJ-Sac was higher than that of INPP5E or PJ ([Fig. 4F *right*](#f4-molce-39-4-322){ref-type="fig"}). These data indicate that the translocation of PJ-Sac is also able to induce PI(4,5)P~2~ depletion. Here, we propose that PJ-Sac dephosphorylates PI(4,5)P~2~ via continuous turnover to PI(4)P to maintain the equilibrium when the PI(4)P is completely depleted. In the plasma membrane, the amount of PI(4)P and PI(4,5)P~2~ is maintained at an almost 1:1 ratio by inositol polyphosphate 5-phosphatases ([@b18-molce-39-4-322]). Altogether, it seems that PI(4)P depletion by PJ-Sac breaks the balance between the amount of PI(4)P and PI(4,5)P~2~, and thus that PI(4,5)P~2~ is dephosphorylated to keep the balance between them.

Another regulator of HVA channels is Ca~V~ β subunits. They regulate the physiological properties and expression levels of HVA channels. They also regulate the channel sensitivity to PI(4,5)P~2~, where the sensitivity is different depending on the types of Ca~V~ β subunits and their subcellular localization. For example, in cells expressing both Ca~V~2.2 channels and Dr-VSP, currents with β3 subunits were markedly decreased, while currents with β2a subunits showed little effect ([@b16-molce-39-4-322]; [@b41-molce-39-4-322]). Therefore, it is meaningful to test the effect of Ca~V~ β subunits on the regulation of Ca~V~2.3 channels by PI(4,5)P~2~ to better understand the regulation mechanism of Ca~V~2.3 channels.

In summary, our study reports that Ca~V~2.3 channels can be regulated by plasma membrane PI(4,5)P~2~. Like other types of HVA Ca~V~ channel, our data demonstrate that Ca~V~2.3 channels are inhibited by PI(4,5)P~2~ depletion. The present results also show that depletion of PI(4)P, a precursor of PI(4,5)P~2~, indirectly affects the Ca~V~2.3 channel activity by slowly decreasing the PI(4,5)P~2~ level in the plasma membrane. This study might contribute to extending our knowledge about regulation of Ca~V~2.3 channels by membrane phosphoinositide.
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![Differential regulation of Ca~V~2.2 and Ca~V~2.3 currents by M~1~R activation. TsA201 cells co-transfected with M~1~ muscarinic receptor (M~1~R) and either Ca~V~2.2 or Ca~V~2.3 channels were treated with 10 μM of Oxo-M for 60 s. (A) Left: Time course of Ca~V~2.2 current regulation. Right: Protocol generating Ca~V~2.2 currents (Upper) and selected current traces designated in left graph (Lower). (B) Left: Time course of Ca~V~2.3 current regulation. Right: Protocol generating Ca~V~2.3 currents (Upper) and selected current traces designated in the left graph (Lower). (C) Summary of % inhibition by Oxo-M treatment in Ca~V~2.2 (n = 13) and Ca~V~2.3 (n = 9) channels. Data are mean ± SEM.](molce-39-4-322f1){#f1-molce-39-4-322}

![Both Ca~V~2.2 and Ca~V~2.3 currents are suppressed by M~1~R activation after full-activation of PKC. Phorbol 12-myristate 13-acetate (PMA, 1 μM) was applied for 2 min in tsA201 cells expressing M~1~R and either Ca~V~2.2 or Ca~V~2.3 channels. Oxo-M was applied for 60 s in the presence of PMA. Normalized current regulation of (A) Ca~V~2.2 channels (n = 9) and (B) Ca~V~2.3 channels (n = 5) by M~1~R stimulation. (C) Summary of % inhibition by Oxo-M of Ca~V~2.2 (n = 9) and Ca~V~2.3 (n = 5) currents. (D) The time constant for Oxo-M-induced inhibition of Ca~V~2.2 (n = 9) and Ca~V~2.3 (n = 5) currents. Data are mean ± SEM.](molce-39-4-322f2){#f2-molce-39-4-322}

![PI(4,5)P~2~ depletion by Dr-VSP decreases both Ca~V~2.2 and Ca~V~2.3 currents. TsA201 cells were co-transfected with Dr-VSP and either Ca~V~2.2 or Ca~V~2.3 channels. (A) Standard protocol for Dr-VSP activation. Cells received a test pulse (a), then a depolarization to +120 mV for 1 s to activate the Dr-VSP, a hyperpolarization to −150 mV for 0.4 s to remove the voltage-dependent inactivation, and a second test pulse (b). Ca~V~2.2 or Ca~V~2.3 currents were measured before and after the Dr-VSP activation at +10 mV or 0 mV, respectively. (B) Left, Ca~V~2.2 current regulation by a membrane depolarization to +120 mV for 1 s in control (-Dr-VSP, n = 8) and cells expressing Dr-VSP (n = 9). Right, Ca~V~2.3 current regulation in control (n = 6) and cells expressing Dr-VSP (n = 6). (C, D) Summary of % inhibition by Dr-VSP-induced PI(4,5)P~2~ depletion in Ca~V~2.2 (C) and Ca~V~2.3 (D) channels. Data are mean ± SEM. ^\*\*\*^ *P* \< 0.001, compared with - Dr-VSP.](molce-39-4-322f3){#f3-molce-39-4-322}

![Plasma membrane PI(4,5)P~2~ levels are reduced by translocation of PJ-Sac, INPP5E, and PJ. TsA201 cells were co-transfected with Lyn~11~-FRB, PH-PLCδ-GFP, and one of the following four constructs: PJ-Dead, PJ-Sac, INPP5E, or PJ. (A) Construct diagrams of the four translocatable phosphoinositide phosphatases. (B) Diagram of the chemically induced dimerization (CID) system. Rapamycin triggers the translocation of cytoplasmic phosphatases to the plasma membrane. (C) Confocal images of cells expressing PJ-Dead (upper left), PJ-Sac (upper right), INPP5E (lower left), or PJ (lower right) with PH-PLCδ-GFP. Images are from before (Upper) and after (Lower) the application of rapamycin (1 μM) for 180 s (Scale bar, 5 μm). (D) Relative cytosolic intensity of PH-PLCδ-GFP (Green) and translocatable enzyme (Red) for the cells in (C). (E) Summary graph of % decrease in cytosolic translocatable enzymes and of % increase in cytosolic PH-PLCδ-GFP by addition of rapamycin (n = 4 for PJ-Dead; n = 10 for PJ-Sac; n = 7 for INPP5E; and n = 9 for PJ). (F) Summary graph of the time constant for rapamycin-induced decrease in cytosolic translocatable enzymes and for rapamycin-induced increase in cytosolic PH-PLCδ-GFP (n = 4 for PJ-Dead; n = 10 for PJ-Sac; n = 7 for INPP5E; and n = 9 for PJ). ^\*^ *P* \< 0.05, ^\*\*^ *P* \< 0.01, and ^\*\*\*^ *P* \< 0.001, with one-way ANOVA followed by Bonferroni post-hoc test.](molce-39-4-322f4){#f4-molce-39-4-322}

![Ca~V~2.2 currents were suppressed by depletion of PI(4,5)P~2~. TsA201 cells were co-transfected with Ca~V~2.2 channels, Lyn~11~-FRB (plasma membrane anchoring protein), and one of the following four constructs: PJ-Dead, PJ-Sac, INPP5E, or PJ. Rapamycin was applied for 60 s. (A) Time courses of Ca~V~2.2 currents in cells expressing PJ-Dead, PJ-Sac, INPP5E, or PJ. (B) Summary graph of % inhibition by rapamycin addition in Ca~V~2.2 currents (n = 6 for PJ-Dead; n = 9 for PJ-Sac; n = 5 for INPP5E; and n = 11 for PJ). (C) Summary graph of the time constant for rapamycin-induced inhibition in Ca~V~2.2 currents (n = 9 for PJ-Sac; n = 5 for INPP5E; and n = 11 for PJ). Data are mean ± SEM. ^\*^ *P* \< 0.05, ^\*\*^ *P* \< 0.01, and ^\*\*\*^ *P* \< 0.001, with one-way ANOVA followed by Bonferroni post-hoc test.](molce-39-4-322f5){#f5-molce-39-4-322}

![Ca~V~2.3 currents were suppressed by depletion of PI(4,5)P~2~. Ca~V~2.3 channels were expressed in tsA201 cells with Lyn~11~-FRB and one of the following four constructs: PJ-Dead, PJ-Sac, INPP5E, or PJ. Rapamycin was added for 60 s. (A) Time courses of Ca~V~2.3 currents in cells expressing PJ-Dead, PJ-Sac, INPP5E, or PJ. (B) Summary of % inhibition by rapamycin in Ca~V~2.3 currents (n = 3 for PJ-Dead; n = 5 for PJ-Sac; n = 6 for INPP5E; and n = 7 for PJ). (C) Summary graph of the time constant for rapamycin-induced inhibition in Ca~V~2.3 currents (n = 5 for PJ-Sac; n = 6 for INPP5E; and n = 7 for PJ). Data are mean ± SEM. ^\*^ *P* \< 0.05, and ^\*\*\*^ *P* \< 0.001, with one-way ANOVA followed by Bonferroni post-hoc test.](molce-39-4-322f6){#f6-molce-39-4-322}
